Literature DB >> 8431161

Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group.

J L Keltner1, C A Johnson, J O Spurr, R W Beck.   

Abstract

The purpose of the present study was to determine the baseline visual field characteristics in 448 patients with acute optic neuritis who were entered into the Optic Neuritis Treatment Trial. The severity and pattern of visual field loss in both the affected and fellow eyes were classified. For affected eyes, diffuse visual field loss was present in 48.2% of eyes, central or centrocecal scotoma was present in 8.3% of eyes, altitudinal or other nerve-fiber bundle-type defects were present in 20.1% of eyes, and a variety of other defects were present in 23.4% of eyes. Visual field involvement was present in the fellow eye at baseline in 308 (68.8%) of the 448 patients. Evidence of a chiasmal or retrochiasmal visual field defect was present in 2.9% of the patients. Since a wide variety of visual field defects can occur with an acute attack of optic neuritis, the pattern of visual field loss is of limited utility in distinguishing optic neuritis from ischemic optic neuropathy and other optic nerve disorders. Asymptomatic visual field defects in the fellow eye are common.

Entities:  

Mesh:

Year:  1993        PMID: 8431161     DOI: 10.1001/archopht.1993.01090020085029

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  41 in total

1.  Variation of visual evoked potential delay to stimulation of central, nasal, and temporal regions of the macula in optic neuritis.

Authors:  S Rinalduzzi; A Brusa; S J Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

2.  Use of a portable head mounted perimetry system to assess bedside visual fields.

Authors:  D A Hollander; N J Volpe; M L Moster; G T Liu; L J Balcer; K D Judy; S L Galetta
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

Review 3.  Corticosteroids for treating optic neuritis.

Authors:  Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal:  Cochrane Database Syst Rev       Date:  2015-08-14

4.  Neuro-ophthalmology for neuroradiologists.

Authors:  D A Jacobs; S L Galetta
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

Review 5.  Current understanding of the epidemiologic and clinical characteristics of optic neuritis.

Authors:  Masanori Nakazawa; Hitoshi Ishikawa; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2021-05-22       Impact factor: 2.447

Review 6.  Human visual skills for brain-computer interface use: a tutorial.

Authors:  Melanie Fried-Oken; Michelle Kinsella; Betts Peters; Brandon Eddy; Bruce Wojciechowski
Journal:  Disabil Rehabil Assist Technol       Date:  2020-06-01

7.  Chronic Invasive Fungal Sinusitis Presenting as Inferior Altitudinal Visual Field Defect.

Authors:  Reema Bansal; Aastha Takkar; Vivek Lal; Amanjit Bal; Sandeep Bansal
Journal:  Neuroophthalmology       Date:  2017-03-16

8.  Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up.

Authors:  Steven E Feldon
Journal:  Trans Am Ophthalmol Soc       Date:  2004

9.  Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study.

Authors:  Alfredo A Sadun; Solange R Salomao; Adriana Berezovsky; Federico Sadun; Anna Maria Denegri; Peter A Quiros; Filipe Chicani; Dora Ventura; Piero Barboni; Jerome Sherman; Erich Sutter; Rubens Belfort; Valerio Carelli
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  Patients' knowledge and perception on optic neuritis management before and after an information session.

Authors:  Albert I Matti; Miriam C Keane; Helen McCarl; Pamela Klaer; Celia S Chen
Journal:  BMC Ophthalmol       Date:  2010-03-21       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.